Retatrutide 10mg Product Information
Retatrutide 10mg — Research Overview Retatrutide 10mg is a next-generation multi-agonist peptide investigated in metabolic research for its activity at GLP-1, GIP, and glucagon receptors. In laboratory settings, this unique receptor profile makes it a valuable tool for studying complex energy-regulation pathways, insulin sensitivity, and lipid metabolism. This compound is supplied by ReGen-X exclusively for scientific and laboratory research. Mechanism of Action (Research Context) In controlled research environments, retatrutide has been shown to interact with three key metabolic signaling pathways: GLP-1 receptor activity – associated with appetite signaling and glucose regulation GIP receptor activity – involved in insulin and fat metabolism Glucagon receptor activity – linked to energy expenditure and lipid mobilization This triple-pathway engagement makes retatrutide of particular interest for metabolic and endocrine research models studying obesity, insulin resistance, and energy homeostasis. Research Summary Retatrutide has been evaluated in pre-clinical and clinical research models for its potential role in: Metabolic rate modulation Glucose and insulin signaling pathways Fat oxidation and lipid transport Appetite and energy balance Its multi-receptor design allows researchers to examine how these pathways interact in complex biological systems. Browse our full range of Metabolic & GLP-1 research compounds. Product Specifications Compound: Retatrutide Quantity: 10mg Form: Lyophilised research peptide Included: 3ml bacteriostatic water (for laboratory reconstitution only) Storage: Refrigerated per laboratory standards Important Research Use Notice This product is sold strictly for laboratory and scientific research use only. It is not a medicine, not a supplement, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied.
